Methodological Training in Statistical Data Mining Related to Drug Development
Three-day training course
October 3-5, 2011
in Berne, Switzerland
given by Dr. Diego Kuonen, CStat PStat CSci, Statoo Consulting
of the training.
In various presentations of FDA's `Critical Path Initiative' the use of
data mining technology and methodology is mentioned as one major approach
to better understand and to optimise various phases of the drug
development process. But how can data mining contribute to achieving operational
excellence? Is data mining in drug development worth the trouble or is it
`statistical déjà vu'?
This three-day training course will provide you with an overview of
the potentials and limitations of data mining in drug development and with
a thorough methodological, practical and, most importantly,
software-vendor independent coverage of state-of-art data mining
techniques. It highlights its
applicability to accumulated data throughout the drug development process,
and it will enable you to apply the presented methodology and its
underlying philosophy to benchmark or your own data.
This training is a `must' for those interested in taking drug development
to its next level.
You can find a detailed description of the training
here and to
register please fill out the registration form.
Please do not hesitate to contact us if you have any questions.